Hair loss abstract
The present invention relates to the use of at least one ecdysteroid
for preparing cosmetic or dermatological compositions intended to
prevent hair loss.
Hair loss claims
1. A method of preventing hair loss comprising: providing a composition
comprising at least one ecdysteroid compound in a cosmetically effective
amount and topically applying same to the scalp or hair so as to
prevent hair loss.
2. The method of claim 1, wherein said at least one ecdysteroid
compound is an ecdysteroid, and ecdysteroid analogue or ecdysteroid
derivative.
3. The method of claim 2 wherein said ecdysteroid, ecdysteroid
analogue or ecdysteroid derivative is chosen from ecdysterone, ecdysone,
muristerone A, ponasterones A, B and C, inokosterone, limnantheoside
A and limnantheoside B, ajugasterone B and ajugasterone C, turkesterone,
dacryhainansterone, kaladasterone, podecdysone, stachysterone, or
the 7,9(11)-dien-6-one ecdysteroids.
4. The method of claim 2, wherein said at least one ecdysteroid
compound is an ecdysteroid
5. The method of claim 4 wherein said ecdysteroid is ecdysterone.
6. The method of claim 2 wherein said at least one ecdysteroid
compound is an ecdysterone analogue.
7. The method of claim 2 wherein said at least one ecdysteroid
compound is an ecdysterone derivative.
8. The method of claim 1 wherein said cosmetically effective amount
of said at least one ecdysteroid compound is between 0.001 and 10%
relative to the total weight of said composition.
9. The method of claim 8 wherein said cosmetically effective amount
of said at least one ecdysteroid compound is between 0.01 and 5%
relative to the total weight of said composition.
10. The method of claim 1 wherein said composition further comprises
a cosmetic agent.
11. The method of claim 1 wherein said cosmetic agent promotes
hair growth.
12. The method of claim 11 wherein said cosmetic agent 2,4-DPO.
13. The method according to any one of claims 1 or 11, further
comprising water, alcohol or one or more cosmetically acceptable
organic solvents.
14. The method according to any one of claims 1 or 11, further
comprising one or more cosmetically acceptable adjuvants.
15. The method according to any one of claims 1 or 11, wherein
said composition is in the form of an aqueous or aqueous-alcoholic
solution, or an aqueous or aqueous-alcoholic gel.
16. The method according to any one of claims 1 or 11, wherein
said composition is in the form of a milk, of a gel, of a mousse,
of a serum or of a lotion.
17. A method of promoting human follicle survival comprising: providing
a composition comprising at least one ecdysteroid compound in a
cosmetically effective amount and topically applying same to the
scalp or hair so as to prevent hair loss.
18. The method of claim 17, wherein said at least one ecdysteroid
compound is an ecdysteroid, and ecdysteroid analogue or ecdysteroid
derivative.
19. The method of claim 18 wherein said ecdysteroid, ecdysteroid
analogue or ecdysteroid derivative is chosen from ecdysterone, ecdysone,
muristerone A, ponasterones A, B and C, inokosterone, limnantheoside
A and limnantheoside B, ajugasterone B and ajugasterone C, turkesterone,
dacryhainansterone, kaladasterone, podecdysone, stachysterone, or
the 7,9(11)-dien-6-one ecdysteroids.
20. The method of claim 18, wherein said at least one ecdysteroid
compound is an ecdysteroid
21. The method of claim 20 wherein said ecdysteroid is ecdysterone.
22. The method of claim 17 wherein said cosmetically effective
amount of said at least one ecdysteroid compound is between 0.001
and 10% relative to the total weight of said composition.
23. The method of claim 22 wherein said cosmetically effective
amount of said at least one ecdysteroid compound is between 0.01
and 5% relative to the total weight of said composition.
24. The method of claim 22 wherein said composition further comprises
a cosmetic agent.
25. The method of claim 24 wherein said cosmetic agent 2,4-DPO.
26. The method according to any one of claims 17, 22 or 25, further
comprising water, alcohol, a cosmetically acceptable organic solvent
or a cosmetically acceptable adjuvant.
27. The method according to claim 26, wherein said composition
is in the form of an aqueous or aqueous-alcoholic solution, or an
aqueous or aqueous-alcoholic gel.
28. The method according to claim 26, wherein said composition
is in the form of a milk, of a gel, of a mousse, of a serum or of
a lotion.
29. A composition for preventing hair loss comprising: at least
one ecdysteroid compound selected from ecdysterone, ecdysone, muristerone
A, ponasterones A, B and C, inokosterone, limnantheoside A and limnantheoside
B, ajugasterone B and ajugasterone C, turkesterone, dacryhainansterone,
kaladasterone, podecdysone, stachysterone, or the 7,9(11)-dien-6-one
ecdysteroidsin in a cosmetically effective amount and a cosmetic
agent, water, alcohol, a cosmetically acceptable organic solvent
or a cosmetically acceptable adjuvant.
30. The composition of claim 1 wherein said cosmetically effective
amount of said at least one ecdysteroid compound is between 0.001
and 10% relative to the total weight of said composition.
Hair loss description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present invention claims the benefit of filing date
of U.S. Provisional Application No. 60/575,441, filed May 28, 2004,
the disclosure of which is hereby incorporated herein by reference.
[0002] The present invention relates to the use of at least one
ecdysteroid for preparing cosmetic or dermatological compositions
intended to prevent hair loss.
[0003] Ecdysteroids are a group of 2,3,14-trihydroxy-.DELTA.-7-6-ketostero-
ids. These molecules are well known in the literature and are cited
in the Merck Index, 10th edition, 1983, page 505, No. 3470.
[0004] It is known that ecdysteroids, and in particular ecdysterone
(or .beta.-ecdysone) play an important role both in the animal kingdom
in insects, where ecdysterone is involved in particular in metamorphosis,
and in the plant kingdom, where these substances appear to play
a role in flowering.
[0005] It has recently been discovered that ecdysteroids regulate
epidermal keratinocyte differentiation. In the hair follicle, these
hormones regulate, or even increase, the synthesis of keratin, which
is the main constituent of the pilar shaft (U.S. Pat. No. 5,609,873).
Those skilled in the art may refer to the article by Eckert and
Rorke (1989, Environment Health Perspective, 80: 109-116).
[0006] Ecdysterone, in particular, has been described as an agent
for improving the appearance of the skin (CN 86 1 06791A) and of
the hair (U.S. Pat. No. 5,609,873), and also the constitutive quality
of the hair fibre (FR 93 10138). In addition, ecdysterone is known
to stimulate hair regrowth in the C3H murine model (H. Ishida et
al., 1999, Biol. Pharma. Bull. 22: 1189-1192).
[0007] Ecdysterone, an insect-moulting hormone, is known to modify
the expression of a certain number of genes in insects via a specific
nuclear receptor. Given the structural similarity between ecdysterone
and steroids such as androgens, oestrogens, etc, which are known
to modify hair growth, the applicant has had the idea of evaluating
the effect of ecdysterone on hair follicle growth and survival.
[0008] The applicant has thus discovered, surprisingly and unexpectedly,
that ecdysterone is capable of promoting human follicle survival,
in vitro and of maintaining, without stimulating, firstly, the mitotic
activity of the cells of the human hair follicle matrix and, secondly,
the programmes for differentiation of the outer sheath and of the
inner sheath of the follicle, while at the same time ensuring the
integrity of the pilar shaft.
[0009] A subject of the invention is thus the use of ecdysteroids
in the preparation of a composition for cosmetic or dermatological
use.
[0010] A subject of the invention is also a cosmetic treatment
process comprising the use of this composition for preventing hair
loss.
[0011] Other subjects of the present application will emerge on
reading the description and the examples which follow.
[0012] A subject of the present invention is thus the use of at
least one ecdysteroid or of at least one ecdysteroid analogue or
of at least one ecdysteroid derivative, for preparing a cosmetic
or dermatological composition intended to prevent hair loss.
[0013] The term "ecdysteroid analogue" is intended to
mean steroids that are generally characterized by a cis-junction
of the A and B rings, a 7-en-6-one chromophore, and a 14.alpha.-hydroxy
group. These analogues generally have a backbone of the cholesterol
(C27) or phytosterol (C28, C29) type (C. Blais et al, 1996, Biochem.
J. 320: 413-419). Currently, more than 250 structural analogues
have been identified (Laffont R. and Wilson I D, 1996, The ecdysone
handbook, 2nd edition, The Chromatographic Society, Nottingham,
U.K., pp 525; see internet site http://ecdybase.org).
[0014] Ecdysteroid derivatives may be products from oxidation of
ecdysteroids or of these analogues, from reduction or from conjugation.
Preferably, the ecdysteroid derivatives are acyl, hydroxyl or deoxyl
derivatives.
[0015] Preferably, the ecdysteroids, ecdysteroid analogues or ecdysteroid
derivatives (collectively referred to as "at least one ecdysteroid
compound," as the context permits) chosen from ecdysterone,
ecdysone, muristerone A, ponasterones A, B and C, inokosterone,
phytoecdysteroids such as limnantheoside A and limnantheoside B
(J. Preston-Mafham & L. Dinan, 2002, Z. Naturforsch. 57c: 144-152),
ajugasterone B and ajugasterone C, turkesterone, podecdysone, stachysterone,
or 7,9(11)-diene-6-one ecdysteroids such as kaladasterone, dacryhainansterone
or 25-hydroxydacryhainansterone (P. C. Bourne et al., 2002, J. Insect
Sci. 2: 11).
[0016] More preferably, the ecdysteroid in question is ecdysterone
or an ecdysterone analogue.
[0017] The ecdysteroids, their analogues or their derivatives are
obtained in isolated form, or in the form of an extract from any
of the available natural sources, or else by means of a process
of chemical synthesis. The main natural sources of ecdysteroids
are insects, marine invertebrates and a large number of plants.
The ecdysteroids can thus be extracted from Achyranthes bidentata,
from Achyranthes aspera, from various species of Paris, from Polypodium
vulgare, from Cyanotis arachnoidea, from Ajuga decumbens, from Ajuga
iva, from Pfaffia paniculata, from Pfaffia iresinoides, from Vitex
glabrata, from Sesuvium portulacastrum, from Serratula sogdiana,
from Serratula tinctoria, from Rhaponticum integrifolium, from Rhaponticum
carthamoides, from various species of Silene, from Lychnis flos-cuculi,
from Cyathula officinalis, from Cyathula capitata or from Bombyx
mori. More particularly, among the plants which can be used for
extraction of the ecdysteroids, in particular of ecdysterone, mention
may be made of Serratula sogdiana and Rhaponticum integrifolium,
which have the advantage that they can be cultivated.
[0018] Moreover, a certain number of ecdysteroids are commercially
available. Ecdysterone is in particular available from Sigma-Aldrich
under the reference H5142.
[0019] The weight-amount of ecdysteroid, of ecdysteroid analogue
or of ecdysteroid derivative is between 0.001 and 10% relative to
the total weight of the composition.
[0020] Preferably, the weight-amount of ecdysteroid, of ecdysteroid
analogue or of ecdysteroid derivative is between 0.01 and 5% relative
to the total weight of the composition.
[0021] The cosmetic composition according to the invention may
also comprise other cosmetic agents intended to promote hair growth,
such as for example aminexil (2,4-DPO, 2,4-diaminopyrimidine-N-oxide).
[0022] The composition according to the invention may also comprise
water and/or one or more cosmetically acceptable organic solvents.
The solvents may be chosen from the group consisting of hydrophilic
organic solvents, lipophilic organic solvents, amphiphilic solvents
or mixtures thereof.
[0023] Among the hydrophilic organic solvents, mention may be made,
for example, of linear or branched lower monoalcohols having from
1 to 8 carbon atoms, such as ethanol, propanol, butanol, isopropanol,
isobutanol, optionally oxyethylenated polyethylene glycols, polyols
such as propylene glycol, isoprene glycol, butylene glycol, glycerol,
sorbitol and its derivatives, glycol ethers and propylene glycol
ethers.
[0024] As amphiphilic organic solvents, mention may be made of
polyols such as propylene glycol derivatives.
[0025] As lipophilic organic solvents, mention may, for example,
be made of fatty esters.
[0026] The composition according to the invention may also comprise
adjuvants such as fatty substances, preserving agents, stabilizers,
opacifiers, softeners, silicones, foaming agents, antioxidants,
pH regulators, emulsifying agents, conventional hydrophilic or lipophilic
thickeners and/or gelling agents, hydrophilic or lipophilic active
agents, fragrances, emulsifiers, sequestering agents, polymers,
acidifying or basifying agents, fillers, free-radical scavengers,
ceramides, moisturizers, vitamins, surfactants, anti-dandruff agents,
propellants, dyes, or any other adjuvant normally used in cosmetics.
[0027] The amount of these various adjuvants are those conventionally
used in the field in question. Those skilled in the art will take
care to choose the optional compound(s) to be added to the composition
according to the invention so as not to impair, or not substantially
impair, the advantageous properties attached to the composition
in accordance with the invention.
[0028] The compositions in accordance with the invention are particularly
suitable in cosmetic and/or dermatological terms, and do not cause
any irritation of the scalp, even after prolonged contact without
rinsing.
[0029] The composition according to the invention may be in any
of the pharmaceutical forms normally used for cosmetic or dermatological
topical application, in particular in the form of an aqueous, aqueous-alcoholic
or oily solution, of an oil-in-water or water-in-oil or multiple
emulsion, or of an aqueous or oily gel.
[0030] The composition may have the appearance of a milk, of a
gel, of a mousse, of a serum or of a lotion.
[0031] The compositions defined above can be applied to the hair
or the scalp, and can be applied, for example, after washing the
scalp.
[0032] These compositions are intended to be used in cases of hair
loss, whether this loss is of natural origin or of drug-related
origin, i.e. subsequent to the absorption of medicinal products
for which hair loss is a side effect.
[0033] A subject of the present invention is also a process of
cosmetic treatment of the scalp with the aim of preventing hair
loss, this process consisting in applying, to the areas in question,
a cosmetically effective amount of a composition containing at least
one ecdysteroid, an ecdysteroid analogue or an ecdysteroid derivative.
[0034] The following examples are intended to illustrate the invention
without, however, being limiting in nature.
EXAMPLE 1
Effect of Ecdysterone on Human Hair Follicle Survival in Vitro
[0035] We had developed and patented a model for a surviving human
follicle in vitro (FR 95-08465) making it possible to evaluate the
effect of a substance on follicle survival and extension.
[0036] We used this in vitro model for evaluating the effect of
ecdysterone on hair follicle growth and survival. Various concentrations
of this substance were tested: 0.01 .mu.g/ml, 0.1 .mu.g/ml, 1 .mu.g/ml
and 10 .mu.g/ml.
[0037] The statistical tests performed on the entire sample show
that the differences observed between the groups are significant.
[0038] The statistical analysis thus shows that ecdysterone has
a positive effect on human hair follicle survival in vitro. Specifically,
ecdysterone at the concentrations from 0.01 .mu.g/ml, 0.1 .mu.g/ml
and 10 .mu.g/ml significantly increases human hair follicle survival
under these culture conditions.
EXAMPLE 2
Effects of Ecdysterone on the Maintenance of Hair Follicle Integrity
in Vitro
[0039] In order to characterize more fully the effect of this substance
on the hair follicle, we monitored the mitotic activity of the bulb
cells and also the various specific differentiation programmes of
the outer sheath, of the inner sheath and of the pilar shaft, in
the presence or absence of this substance.
[0040] The integrity of the follicle compartments after 14 days
of culture was thus monitored by means of antibodies that recognize
markers specific for each of these compartments: the mitosis marker
Ki67, specific for the matrix (S. Commo & B. A. Bernard, 1997,
Br. J. Dermatol. 137: 31-38); keratin K14, specific for the outer
sheath (ibid.); transglutaminase, specific for the inner sheath
(ibid.); and keratin hHa5, specific for the pillar shaft, and in
particular the keratogenic zone and the cuticle (L. Langbein et
al., 1999, J. Biol. Chem. 274: 19874-19884).
[0041] After 14 days of culture, in the absence of ecdysterone,
histological analysis of the hair follicle shows that the Ki67 labelling
decreases, keratin K14 is ectopically expressed, the transglutaminase
expression points to a thickening and a disorganisation of the inner
sheath, and keratin hHa5 shows an alteration in the shaft cuticle.
On the other hand, after 14 days of culture in the presence of ecdysterone
at 0.01 .mu.g/ml, all the markers studied conserve an expression
that is comparable to that of the reference follicle at D=0.
[0042] Ecdysterone therefore opposes the spontaneous degradation
of the follicle and maintains the integrity of the follicular compartments
after 14 days of culture in vitro.
EXAMPLE 3
Cosmetic Composition No. 1 Intended to Prevent Hair Loss
[0043] The following components are weighed out, mixed and solubilized
at ambient temperature.
1 Ecdysterone 9.0 Polypropylene glycol 5.0 Vitamin E 0.1 Diphenhydramine
hydrochloride 0.1 Dipotassium glycyrrhetinate 0.1 Methylparabene
0.2 Ethanol 50.0 Fragrance 1.0
EXAMPLE 4
Cosmetic Composition No. 2 Intended to Prevent Hair Loss
[0044] The following components are weighed out, heated separately
and dissolved at 80.degree. C. before mixing.
2 Ponasterone C 0.5 Inokosterone 0.5 Stearyl methylammonium chloride
3.5 Polypropylene glycol 5.0 Liquid paraffin 2.0 Methylpolysiloxane
2.0 Behenyl alcohol 4.0 Fragrance 0.5 Purified water 82.0
|